CONTROLLED SUBSTANCES ACT

Amendments

Drugs: decriminalize, expunge prior convictions, tax products to create programs for those adversely affected by War on Drugs, and provide assistance and collect data on small businesses relative to marijuana (H.R. 3617), H4106, H4107, H4108 [1AP]

——— decriminalize, expunge prior convictions, tax products to create programs for those hurt by War on Drugs, and provide assistance and collect data on small businesses relative to marijuana (H.R. 3617), consideration (H. Res. 1017), H4031 [31MR]

——— streamline, coordinate and expand research and foster increased communication between doctors and patients relative to cannabidiol and other marijuana components and their medical benefits (S. 253), S1781 [24MR]

Temporary Reauthorization and Study of the Emergency Scheduling of Fentanyl Analogues Act: extend (S. 1216), S955 [2MR]

Articles and editorials

Are You High? The Science of Testing for Marijuana Impairment Is Hazy, and Evolving. Lawmakers, Police, Prosecutors Grapple With How To Define Marijuana Impairment, H4101 [1AP]

Cannabis Liberalization in the US—The Policy Landscape, H4103–H4105 [1AP]

Is Marijuana Addictive?, H4099 [1AP]

Legalized Marijuana Linked to a Sharp Rise in Car Crashes, H4100 [1AP]

‘‘Talk About Clusterf---’’—Why Legal Weed Didn’t Kill Oregon’s Black Market, H4088–H4090 [1AP]

U.S. Grapples With How To Gauge Just How High Cannabis Users Are, H4102 [1AP]

Bills and resolutions

Agriculture: promote production of hemp and hemp products (see H.R. 6645), H1074 [8FE]

DEA: codify temporary scheduling order for fentanyl-related substances by adding fentanyl-related substances to schedule I of Controlled Substances Act (see S. 3457), S118 [10JA]

——— include fentanyl-related substances under schedule I of Controlled Substances Act, designating they have high potential for abuse and no medical use (see H.R. 6946), H1328 [7MR]

——— make permanent scheduling of fentanyl-related substances (see H.R. 6713), H1119 [11FE]

——— modify registration requirements relative to research with controlled substances (see S. 5123), S6779 [17NO]

——— provide for life imprisonment for certain offenses involving fentanyl (see H.R. 6439), H288 [20JA]

——— require removal of drug from scheduling within certain period pursuant to recommendation of Dept. of HHS (see H.R. 8931), H8064 [21SE]

Dept. of Homeland Security: authorize to perform certain drug enforcement functions (see H.R. 9093), H8370 [30SE]

Dept. of Justice: register practitioners to transport controlled substances to States in which practitioner is not registered to administer substances at places outside of principal places of business (see H.R. 7259), H3895 [28MR]

——— require electronic communication service providers and remote computing services to report unlawful sale and distribution of controlled substances (see S. 4858), S4638 [15SE]

——— require electronic communication service providers and remote computing services to report unlawful sale and distribution of counterfeit substances and certain controlled substances (see S. 5297), S7311 [19DE]

Drugs: allow persons authorized to collect controlled substances for destruction through consumer return program to open and inspect packages and transport drugs to another location for destruction (see H.R. 6896), H1274 [2MR]

——— amend laws relative to registration of opioid treatment programs to increase stakeholder input from relevant communities and ensure such programs are treating patients in need (see H.R. 8917), H8009 [20SE]

——— amend to fix technical error in definitions (see S. 4235), S2544 [17MY] (see H.R. 9178), H8395 [14OC]

——— create expungement mechanism and process to petition for expungement for low-level marijuana crimes and study impact of expungements issued (see H.R. 8557), H7403 [28JY]

——— decriminalize, expunge prior convictions, tax products to create programs for those adversely affected by War on Drugs, and provide assistance and collect data on small businesses relative to marijuana (see S. 4591), S3611 [21JY]

——— decriminalize, expunge prior convictions, tax products to create programs for those hurt by War on Drugs, and provide assistance and collect data on small businesses relative to marijuana (H.R. 3617), consideration (see H. Res. 1017), H4071 [31MR]

——— increase number of cannabis manufacturers registered under Controlled Substances Act for legitimate research purposes and allow VA health care providers to recommend federally-approved cannabis clinical trials (see H.R. 9679), H10055 [22DE]

——— prohibit certain acts related to fentanyl, analogues of fentanyl, and counterfeit substances (see S. 4151), S2358 [5MY] (see H.R. 8175), H5822 [22JN]

——— prohibit deceptive sale of fentanyl (see S. 4984), S5225 [28SE]

——— prohibit Federal funding for any State, local, Tribal, or private entity that operates or controls injection center in violation of Controlled Substances Act (see H.R. 7029), H1422 [9MR]

——— prohibit Federal funding to operate or control injection center in violation of Controlled Substances Act (see H.R. 6741), H1123 [15FE]

——— prohibit manufacturing or distributing candy-flavored controlled substances for minors (see H.R. 8839), H7880 [15SE]

——— provide for punishment for knowing distribution of fentanyl if death results (see H.R. 8228), H5918 [24JN]

——— streamline, coordinate, and expand research and foster increased communication between doctors and patients relative to cannabidiol and other marijuana components and their medical benefits (see H.R. 8454), H7065 [21JY]

Temporary Reauthorization and Study of the Emergency Scheduling of Fentanyl Analogues Act: extend (see S. 5167), S6941 [1DE] (see H.R. 9595), H9902 [15DE]

Letters

Marijuana Opportunity Reinvestment and Expungement (MORE) Act: several organizations, H4105 [1AP]

Medical Marijuana Research Act: Representative Nadler, Committee on the Judiciary (House), E371 [7AP]

——— Representative Pallone, Committee on Energy and Commerce (House), E371 [7AP]

Lists

Votes recorded by proxy on H. Res. 1017, consideration of H.R. 3617, Marijuana Opportunity Reinvestment and Expungement (MORE) Act, H4033 [31MR]

Votes recorded by proxy on H.R. 3617, Marijuana Opportunity Reinvestment and Expungement (MORE) Act, H4115 [1AP]

Votes recorded by proxy on H.R. 5657, Medical Marijuana Research Act, H4144 [4AP]

Votes recorded by proxy on H.R. 8454, Medical Marijuana and Cannabidiol Research Expansion Act, H7146 [26JY]

Votes recorded by proxy on Lamb amendment to H.R. 3617, Marijuana Opportunity Reinvestment and Expungement (MORE) Act, H4111 [1AP]

Votes recorded by proxy on Latta motion to recommit H.R. 3617, Marijuana Opportunity Reinvestment and Expungement (MORE) Act, H4115 [1AP]

Votes recorded by proxy on previous question to H. Res. 1017, consideration of H.R. 3617, Marijuana Opportunity Reinvestment and Expungement (MORE) Act, H4032 [31MR]

Motions

Drugs: decriminalize, expunge prior convictions, tax products to create programs for those adversely affected by War on Drugs, and provide assistance and collect data on small businesses relative to marijuana (H.R. 3617), H4112 [1AP]

Notices

Estimated budget effects of H.R. 5657, Medical Marijuana Research Act, H4152 [4AP]

Estimated budget effects of H.R. 8454, Medical Marijuana and Cannabidiol Research Expansion Act, H7163 [26JY]

Remarks in House

DEA: clarify process for registrants to exercise due diligence upon discovering suspicious orders, H5791 [22JN]

——— delay implementation of separate registration requirement for dispensing narcotic drugs categorized in schedules with lower potential for abuse that are intended for maintenance or detoxification treatment, H5793–H5795 [22JN]

——— eliminate separate registration requirement for dispensing narcotic drugs categorized in schedules with lower potential for abuse that are intended for maintenance or detoxification treatment, H5777 [22JN]

——— include fentanyl-related substances under schedule I of Controlled Substances Act, designating they have high potential for abuse and no medical use (H.R. 6946), H7886 [19SE]

——— include fentanyl-related substances under schedule I of Controlled Substances Act, designating they have high potential for abuse and no medical use (S. 339), H39 [11JA]

——— make permanent scheduling of fentanyl-related substances (H.R. 6184), H352, H353, H901, H902, H903 [2FE], H979, H982 [7FE], H1021, H1062 [8FE], H4094 [1AP], H8083 [22SE], H8174–H8177 [28SE]

——— provide for life imprisonment for certain offenses involving fentanyl (H.R. 6439), H901 [2FE], H1063 [8FE]

Drugs: ban use of ingredients or flavor additives in marijuana-infused products, H4030 [31MR]

——— conduct studies on impact of legalization of marijuana to workplaces and schools and children, H4107, H4108 [1AP]

——— decriminalize, expunge prior convictions, tax products to create programs for those adversely affected by War on Drugs, and provide assistance and collect data on small businesses relative to marijuana (H.R. 3617), H3973 [30MR], H4078–H4116, H4119 [1AP], H4147 [4AP], H4160 [5AP]

——— decriminalize, expunge prior convictions, tax products to create programs for those hurt by War on Drugs, and provide assistance and collect data on small businesses relative to marijuana (H.R. 3617), consideration (H. Res. 1017), H4023–H4033 [31MR]

——— improve medical research on marijuana by simplifying registration process to conduct research, facilitating access for such research, and allowing private manufacture and distribution for research purposes (H.R. 5657), H4136–H4140 [4AP]

——— increase number of days before which certain controlled substances for maintenance or detoxification treatment must be administered, H5791 [22JN], H5835 [23JN]

——— make marijuana legal at Federal level, incentivize States to change marijuana laws that disproportionately impact minority communities, and allow retroactive review of marijuana sentences, H4095 [1AP]

——— reduce threshold for mandatory minimum penalties for certain fentanyl-related offenses (H.R. 5694), H1064 [8FE]

——— require child-resistant packaging and warning labels detailing dangers posed to pregnant women and unborn babies for marijuana products, H4030 [31MR]

——— streamline, coordinate, and expand research and foster increased communication between doctors and patients relative to cannabidiol and other marijuana components and their medical benefits (H.R. 8454), H7120–H7124 [26JY]

Health care professionals: require prescribers of controlled substances to complete training on treating patients with opioid and other substance use disorders and incorporate such training in medical school curricula (H.R. 2067), H5737 [22JN]

Remarks in Senate

Crime: eliminate disparity in sentencing for crack and powder cocaine offenses (H.R. 1693), S9727–S9729 [21DE]

——— eliminate disparity in sentencing for crack and powder cocaine offenses (H.R. 1693), unanimous-consent request, S9728 [21DE]

DEA: codify temporary scheduling order for fentanyl-related substances by adding fentanyl-related substances to schedule I of Controlled Substances Act (S. 3457), S120 [10JA], S272 [18JA]

——— include fentanyl-related substances under schedule I of Controlled Substances Act, designating they have high potential for abuse and no medical use (S. 1006), S5135–S5137 [28SE]

——— include fentanyl-related substances under schedule I of Controlled Substances Act, designating they have high potential for abuse and no medical use (S. 1006), unanimous-consent request, S5136, S5137 [28SE]

Drugs: amend to fix technical error in definitions (S. 4235), S4624 [14SE]

——— decriminalize, expunge prior convictions, tax products to create programs for those adversely affected by War on Drugs, and provide assistance and collect data on small businesses relative to marijuana (S. 4591), S3581 [21JY]

——— decriminalize marijuana at Federal level and provide for taxation and regulation of marijuana products, S620 [10FE]

——— prohibit deceptive sale of fentanyl (S. 4984), S5130, S5131 [28SE]

——— prohibit deceptive sale of fentanyl (S. 4984), unanimous-consent request, S5130, S5131 [28SE]

——— streamline, coordinate, and expand research and foster increased communication between doctors and patients relative to cannabidiol and other marijuana components and their medical benefits (H.R. 8454), S6736, S6746 [16NO]

——— streamline, coordinate and expand research and foster increased communication between doctors and patients relative to cannabidiol and other marijuana components and their medical benefits (S. 253), S1784 [24MR]

Temporary Reauthorization and Study of the Emergency Scheduling of Fentanyl Analogues Act: extend (S. 1216), S928–S930 [2MR], S4892 [21SE], S5137 [28SE]

——— extend (S. 1216), unanimous-consent request, S928, S929 [2MR], S5137 [28SE]

Reports

Background On—Marijuana and Impaired Driving: Insurance Information Institute, H4098 [1AP]

Reports filed

Consideration of H.R. 3617, Marijuana Opportunity Reinvestment and Expungement (MORE) Act: Committee on Rules (House) (H. Res. 1017) (H. Rept. 117–285), H4071 [31MR]

Marijuana Opportunity Reinvestment and Expungement (MORE) Act: Committee on the Judiciary (House) (H.R. 3617) (H. Rept. 117–276), H3862 [24MR]

Statements

Marijuana and Teens: American Academy of Child and Adolescent Psychiatry, H4098 [1AP]

Marijuana Legalization: American Academy of Child and Adolescent Psychiatry, H4097 [1AP]

Texts of

H. Res. 1017, consideration of H.R. 3617, Marijuana Opportunity Reinvestment and Expungement (MORE) Act, H4023 [31MR]

H.R. 3617, Marijuana Opportunity Reinvestment and Expungement (MORE) Act, H4079–H4087 [1AP]

H.R. 5657, Medical Marijuana Research Act, H4136–H4138 [4AP]

H.R. 8454, Medical Marijuana and Cannabidiol Research Expansion Act, H7120–H7122 [26JY]

S. 4235, amend Controlled Substances Act to fix technical error in definitions, S4625 [14SE]